2.83
  Price0.35%   -0.0100
(Pre-market: 2.86 +0.0300 +1.06%)
May-15-22 03:30AM Communiqué de presse: Sarclisa® (isatuximab) en association permet d’obtenir un allongement sans précédent la survie médiane sans progression des patients atteints d’un myélome multiple en rechute traités par un inhibiteur du protéasomeGlobeNewswire Inc.
May-11-22 06:20AM Is WisdomTree Europe Hedged Equity ETF (HEDJ) a Strong ETF Right Now?Zacks Investment Research
02:00AM Communiqué de presse: De nouvelles analyses des données relatives au nirsevimab confortent son efficacité contre le VRS GlobeNewswire Inc.
May-10-22 08:21AM Jim Cramer Shares His Take On Silicon Motion Technology, New York Community Bancorp And MoreBenzinga
May-07-22 01:44AM Tracking Ken Fisher's Fisher Asset Management Portfolio - Q1 2022 UpdateSeeking Alpha
May-04-22 06:00AM Communiqué de presse : Foundation S, nouveau fer de lance du mécénat de SanofiGlobeNewswire Inc.
Apr-28-22 01:30AM Press Release: Sanofi continues to deliver strong business EPS growth driven by higher sales and improved margins in Q1GlobeNewswire Inc.
Apr-27-22 01:30AM Banco Santander Central Hispano (SAN) Q1 2022 Earnings Call TranscriptThe Motley Fool
Apr-26-22 02:28AM Sanofi: Information concerning the total number of voting rights and shares – March 2022GlobeNewswire Inc.
06:47AM Communiqué de presse : Sanofi s’associe à McLaren Racing pour accélérer l’excellence de son outil industrielGlobeNewswire Inc.
Apr-14-22 01:00AM Communiqué de presse: Publication, dans le New England Journal of Medicine, des résultats positifs de phase I/II du rilzabrutinib dans le traitement de la thrombocytopénie immuneGlobeNewswire Inc.
Apr-12-22 12:25PM Sanofi - AGM 03.05.2022 - Availability of Preparatory DocumentsGlobeNewswire Inc.
Apr-07-22 01:00AM Communiqué de presse: La Commission européenne approuve Dupixent® (dupilumab) pour le traitement des enfants âgés de 6 à 11 ans présentant un asthme sévère avec signature inflammatoire de type 2GlobeNewswire Inc.
Apr-04-22 01:00AM Communiqué de presse: La FDA accepte d’accorder un examen prioritaire à Dupixent® (dupilumab) pour le traitement des patients de 12 ans et plus souffrant d’œsophagite à éosinophilesGlobeNewswire Inc.
Apr-01-22 10:17AM Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2022Benzinga
01:30AM Press Release: EUROAPI listing on Euronext Paris expected on May 6, 2022GlobeNewswire Inc.
Mar-31-22 01:00AM Press Release: Sanofi successfully priced an inaugural sustainability-linked bond indexed on access to medicinesGlobeNewswire Inc.
Mar-30-22 01:30AM Communiqué de presse : Mise en ligne du document «Q1 2022 Memorandum for modelling purposes»GlobeNewswire Inc.
Mar-29-22 01:00AM Press Release: Sanofi and IGM Biosciences Announce Collaboration Agreement for Oncology, Immunology and Inflammation Targets GlobeNewswire Inc.
Mar-28-22 09:00AM Communiqué de presse: Sanofi poursuit sa trajectoire de leadership en immunologie avec Dupixent® (dupilumab) comme levier de croissanceGlobeNewswire Inc.
03:00AM Press Release: Xenpozyme® (olipudase alfa) approved in Japan, first and only approved therapy indicated to treat acid sphingomyelinase deficiencyGlobeNewswire Inc.
Mar-26-22 12:45PM Sanofi: Informations relatives au nombre de droits de vote et d'actions – FEVRIER 2022 GlobeNewswire Inc.
10:00AM Press release: Late-breaking Phase 3 data at AAD 2022 show Dupixent® (dupilumab) significantly improved signs and symptoms of prurigo nodularisGlobeNewswire Inc.
Mar-25-22 02:46AM Why StoneCo Plummeted TodayThe Motley Fool
Mar-21-22 10:09AM Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2022Benzinga
Mar-18-22 07:48AM Press Release: Sanofi moves forward with EUROAPI listing on Euronext ParisGlobeNewswire Inc.
Mar-16-22 10:06AM HSBC to Shut 69 UK Branches Amid Shift to Digital BankingZacks Investment Research
06:18AM Communiqué de presse : Sanofi et Seagen annoncent leur collaboration pour le développement et la commercialisation de plusieurs nouveaux conjugués anticorps-médicamentGlobeNewswire Inc.
Mar-15-22 02:00AM Sanofi announces €300 million collaboration with Blackstone Life Sciences to advance an innovative treatment for multiple myelomaGlobeNewswire Inc.
Mar-14-22 02:00AM Sanofi fait le point sur l’étude de phase II évaluant l’amcenestrant dans le traitement du cancer du sein ER+/HER2- au stade avancé ou métastatiqueGlobeNewswire Inc.
Mar-09-22 01:00AM Efanesoctocog alfa met primary and key secondary endpoints in pivotal study in hemophilia A, demonstrating superiority to prior factor prophylaxis treatmentGlobeNewswire Inc.
Mar-08-22 08:25AM Sanofi reconnue par S&P parmi les entreprises les plus engagées en faveur du développement durable GlobeNewswire Inc.
06:20AM Is WisdomTree Europe Hedged Equity ETF (HEDJ) a Strong ETF Right Now?Zacks Investment Research
Mar-03-22 02:00AM Nirsevimab significantly protected infants against RSV disease in Phase 3 trialGlobeNewswire Inc.
Mar-01-22 10:42AM Crude Oil Sharply Higher As 40-Mile Russian Military Convoy Heads To KyivInvesting.com
Feb-26-22 12:05PM Des données de phase III de dernière minute présentées au Congrès annuel de l’AAAAI 2022 montrent que Dupixent® (dupilumab) améliore significativement les signes et symptômes de l’œsophagite à éosinophiles GlobeNewswire Inc.
12:00PM Des données de phase III de dernière minute présentées au Congrès annuel de l’AAAAI 2022 montrent que Dupixent® (dupilumab) diminue significativement les démangeaisons et l’urticaire des patients souffrant d’urticaire chronique spontanéeGlobeNewswire Inc.
Feb-24-22 07:54AM WHO says omicron subvariant is not stopping global cases from falling, and U.S. nearing 940,000 COVID deathsMarketWatch
Feb-23-22 02:49AM WHO says omicron subvariant is not stopping global cases from falling, and U.S. nearing 940,000 COVID deathsMarketWatch
02:16AM Filing of the 2021 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial ReportGlobeNewswire Inc.
Feb-23-22 01:21AM WHO says omicron subvariant is not stopping global cases from falling, and U.S. nearing 940,000 COVID deathsMarketWatch
10:16AM WHO says omicron subvariant is not stopping global cases from falling, and U.S. nearing 940,000 COVID deathsMarketWatch
Feb-23-22 05:20AM Sanofi et GSK vont demander l’approbation réglementaire de leur vaccin contre la COVID-19GlobeNewswire Inc.
05:15AM Sanofi and GSK to seek regulatory authorization for COVID-19 vaccineGlobeNewswire Inc.
Feb-22-22 01:14AM Sanofi: Informations relatives au nombre de droits de vote et d'actions - JANVIER 2022GlobeNewswire Inc.
12:32PM Le Conseil d’administration de Sanofi propose la nomination de Carole Ferrand, Emile Voest et Antoine Yver en qualité d’administrateurs indépendantsGlobeNewswire Inc.
Feb-18-22 01:00AM Point d’actualité sur le programme de phase III relatif à Dupixent® (dupilumab) dans le traitement de l’urticaire chronique spontanéeGlobeNewswire Inc.
Feb-10-22 01:00AM FDA accepts Dupixent® (dupilumab) for Priority Review in children aged 6 months to 5 years with moderate-to-severe atopic dermatitisGlobeNewswire Inc.
Feb-09-22 12:00PM Olipudase alfa shown to provide sustained improvement across multiple clinical manifestations of ASMDGlobeNewswire Inc.
Feb-04-22 05:00AM FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin diseaseGlobeNewswire Inc.
Banco Santander, S.A., together with its subsidiaries, provides various retail and commercial banking products and services for individual and corporate clients worldwide. It offers demand and time deposits, and current and savings accounts; certificates of deposit; mortgages, auto finance, and personal loans; working capital finance; and debit and credit cards, as well as life and non-life insurance products. The company also provides cash management, trade finance, custody and securities, and securitization services; corporate loans; capital market products; and syndicated corporate finance services. In addition, it is involved in the corporate banking, treasury, and investment banking activities; fixed income and equity derivatives; trading and hedging derivatives; and brokerage of equities. Further, the company offers asset management, private banking, and processing services, as well as mobile and online banking services. It operates through a network of 13,697 branches. The company was formerly known as Banco Santander Central Hispano S.A. and changed its name to Banco Santander, S.A. in June 2007. Banco Santander, S.A. was founded in 1856 and is headquartered in Madrid, Spain.
Cap:    |  Volume (24h):